We are looking for adults ages 18 to 55 who have been diagnosed with migraine. The CGBC Study will consist of five visits over a period of up to five weeks. Individuals will be evaluated to determine their eligibility to participate in this study. Each person who qualifies will receive the study drug and study-related medical exams at no cost, as well as compensation for time and travel.
This study is researching an FDA-approved treatment currently available for migraine prevention.
Inclusion Criteria
Have a diagnosis of migraine, with or without aura
Have a frequency of less than 15 monthly headache days
Participants can be on no more than 1 other migraine preventive treatment
Exclusion Critera
Participants with a history of GI problems
Participants with type 1 or type 2 diabetes
BMI <40 kg/m2
Participants with cardiac pacemakers or other implanted or portable electromechanical device
Participants currently on mAb CGRP antagonists
If you would like more information or to find out if you are eligible to participate please contact Rebecca Hogan at 716-558-5670.
Subscribe To Our Newsletter
Sign up to receive email updates on announcements, new services added, company updates & more!
Want to participate in a study?
Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.